Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Zy_Co_V-D
gptkb:Corixa_Corporation |
| gptkbp:awards |
industry recognition
sustainability awards innovation awards |
| gptkbp:clinical_trial |
gptkb:drug
malaria vaccine HIV vaccine RSV vaccine |
| gptkbp:collaborations |
government agencies
non-profit organizations academic institutions |
| gptkbp:employees |
gptkb:television_series
|
| gptkbp:focus_area |
vaccines
|
| gptkbp:founded |
gptkb:2000
|
| gptkbp:global_presence |
over 100 countries
|
| gptkbp:headquarters |
RTP, North Carolina, USA
|
| https://www.w3.org/2000/01/rdf-schema#label |
GSK Vaccines
|
| gptkbp:innovation |
vaccine delivery systems
m RNA technology vaccine adjuvants |
| gptkbp:market |
significant in global vaccine market
|
| gptkbp:mission |
improve global health
|
| gptkbp:parent_company |
gptkb:Glaxo_Smith_Kline
|
| gptkbp:partnership |
gptkb:Medicago
gptkb:Sanofi_Pasteur |
| gptkbp:products |
influenza vaccines
pneumococcal vaccines tetanus vaccines diphtheria vaccines pertussis vaccines shingles vaccines |
| gptkbp:regulatory_compliance |
gptkb:FDA
gptkb:WHO gptkb:EMA |
| gptkbp:research_focus |
oncology
infectious diseases immunology |
| gptkbp:revenue |
billions
|
| gptkbp:sustainability_initiatives |
community health
environmental responsibility access to vaccines |
| gptkbp:vision |
a world where diseases are prevented through vaccination.
|
| gptkbp:bfsParent |
gptkb:Glaxo_Wellcome
gptkb:Smith_Kline_Corporation |
| gptkbp:bfsLayer |
5
|